Hauptinhalt

Bibliografische Daten

Dokument US000006288104B1 (Seiten: 13)

Bibliografische Daten Dokument US000006288104B1 (Seiten: 13)
INID Kriterium Feld Inhalt
54 Titel TI [EN] Pharmaceutical compositions containing mesembrine and related compounds
71/73 Anmelder/Inhaber PA PHARMA NATURA PTY LTD, ZA
72 Erfinder IN GERICKE NIGEL PETER, ZA ; VAN WYK BEN-ERIK, ZA
22/96 Anmeldedatum AD 22.03.1999
21 Anmeldenummer AN 19483699
Anmeldeland AC US
Veröffentlichungsdatum PUB 11.09.2001
33
31
32
Priorität PRC
PRN
PRD
GB
9701493
03.06.1997
33
31
32
PRC
PRN
PRD
ZA
964595
04.06.1996
51 IPC-Hauptklasse ICM A61K 31/40
51 IPC-Nebenklasse ICS
IPC-Zusatzklasse ICA
IPC-Indexklasse ICI
Gemeinsame Patentklassifikation CPC A61K 31/404
A61P 25/04
A61P 25/20
A61P 25/22
A61P 25/24
A61P 25/32
A61P 3/00
A61P 3/04
A61P 43/00
C07D 209/08
C07D 209/32
MCD-Hauptklasse MCM C07D 209/12 (2006.01)
MCD-Nebenklasse MCS A61K 31/00 (2006.01)
A61K 31/403 (2006.01)
A61K 31/404 (2006.01)
A61K 31/40 (2006.01)
A61K (2006.01)
A61P 25/04 (2006.01)
A61P 3/00 (2006.01)
A61P 3/04 (2006.01)
A61P 43/00 (2006.01)
C07D 209/08 (2006.01)
C07D 209/32 (2006.01)
C07D (2006.01)
MCD-Zusatzklasse MCA
57 Zusammenfassung AB [EN] There is disclosed the use of mesembrine and related compounds (e.g. mesembranol, mesembranone) as scrotonin-uptake inhibitors, pharmaceutical compositions comprising such compounds or dry material or an extract of plants from the Mesembryanthemaceae family (e.g. Sceletium (Aizoaceae) tortuosum) containing a standardized content of said compounds, for use in the treatment of depressive states, psychological or psychiatric disorders with an anxiety component, alcohol and drug dependence, bulimia nervosa and obsessive-compulsive disorders. Also disclosed are new derivatives of mesembrine.
56 Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt
CT
56 Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt
CT JP000046043538A
JP000046043539A
DE000003604112A1
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt
CTNP
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt
CTNP Capps et al., "Sceletium Alkaloids, Part 7.1 Structure and Absolute Stereochemistry of (-)-Mesembrane and 3'-Methoxy-4'-O-methyljoubertiamine, Two Minor Bases from S. Namaquense L. Bolus: X-Ray Analysis of (-)-Mesembrane Hydrochloride Monohydrate," J. Chem. Soc. Perkins Trans. 8:1098-1104 (1977). 1;
Hoshino et al., "Synthesis of Sceletium and Amaryllidaceae Alkaloids, (±)-Mesembrine and (±)-Dihydromaritidine, (±)Epidihydromaritidine, (±-Elwesine, and (±)-Epielwesine1)," Chem. Pharm. Bull. 35:2734-2743 (1987). 1;
Jeffs et al., "Sceletium Alkaloids. VI. Minor Alkaloids of S. namaquense and S. strictum," J. Org. Chem. 39:2703-2710 (1974). 1;
Jeffs et al., "Total Syntheses of (±)-Joubertinamine, and (±)-N-Demethylmesembrenone," J. Org. Chem. 48:3861-3863 (1983). 1;
Kruger et al., "Minor Alkaloids from Sceletium Strictum L. Bol. The Structure of N-Demethylmesembrenol and N-Demthylmesembranol," Journal of the South African Chemical Institute XXIV:235-237 (1971). 1;
Langlois et al., "Recherches Dans La Serie Des Aryl-3 Pyrrolidines-II, Syntheses de Produits Apparentes a la Mesembrine et a La Crinine," Tetrahedron 27:5641-5652 (1971). 1;
Pfaffli et al., "Demethylierungen am Mesembrine," Helvetica Chimica Acta 56:347-355 (1973). 1;
Smith et al., "Psychoactive constituents of the genus Sceletium N.E.Br. and otehr Mesembryanthemaceae: a review," Journal of Ethnopharmacology 50:119-130 (1996). 1;
Taguchi et al., "Synthesis of Octahydroindole Derivatives," Tetrahedrom Letters, 55:5763-5766 (1968). 1;
Taguchi et al., "Synthesis of Octhydroindole Derivatives," Chem. Pharm. Bull. 18:1008-1014 (1970). 1
Zitierende Dokumente AU002010224485B2
EP000004419514A4
GB000002616343A
US000007979117B2
US000008552051B2
US000008980338B2
US000009381220B2
US000009576694B2
US000009752932B2
US000010175106B2
US000010179155B2
US000011173142B2
US000011999694B2
US000012059404B2
US000012269800B2
US020040267189A1
US020050192339A1
US020050239841A1
US020120004275A1
US020150080447A1
US020220031660A1
WO002003035166A2
WO002003035167A2
WO002005051380A1
WO002005051381A1
WO002005068016A1
WO002006114402A1
WO002010106494A1
WO002010106495A1
WO002011092547A1
WO002014155351A1
WO002023004428A1
WO002023069455A1
WO002023076533A1
WO002023230049A1
WO002024015559A3
WO002024102461A1
WO002024102991A1
WO002024137898A1
WO002024173800A3
Sequenzprotokoll
Prüfstoff-IPC ICP A61K 31/40